|
|
|
Insider
Information: |
Stamoulis Christiana |
Relationship: |
EVP & Chief Financial ... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
176,167 |
|
Indirect Shares
|
939 |
|
|
Direct
Value |
$26,348,657 |
|
|
Indirect Value
|
$410,803 |
|
|
Total
Shares |
177,106 |
|
|
Total
Value |
$26,759,460 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
SVP, Corp Strategy & B... |
2013-07-15 |
40,712 |
2013-07-15 |
939 |
Premium* |
|
Hologic Inc |
HOLX |
Director |
2024-03-07 |
45,472 |
2011-11-01 |
0 |
Premium* |
|
Incyte Corp |
INCY |
EVP & Chief Financial ... |
2024-02-14 |
89,983 |
2019-02-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2011-02-03 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
23,813 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2011-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,445 |
11,445 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2012-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,997 |
16,442 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,372 |
20,814 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-02-05 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
45,712 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2017-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,206 |
30,206 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2018-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,406 |
35,039 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2019-02-11 |
4 |
A |
$80.21 |
$824,960 |
D/D |
10,285 |
10,285 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
37,175 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2020-02-11 |
4 |
A |
$76.14 |
$324,966 |
D/D |
4,268 |
14,869 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
39,392 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2020-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,661 |
21,067 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2020-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,232 |
22,299 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,522 |
33,821 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2021-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,478 |
40,870 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,853 |
40,781 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,463 |
57,462 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
42,435 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2022-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,317 |
73,783 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2023-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,980 |
77,639 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
43,900 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2023-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,246 |
82,993 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
7,377 |
89,983 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
45,472 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-04-29 |
4 |
AS |
$79.08 |
$6,598,756 |
D/D |
(82,999) |
40,712 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|